Chantal Visser, MD

PhD candidate, MD
Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Rotterdam, Zuid-Holland, Netherlands

Chantal Visser is a PhD student supervised by M.J.H.A. Kruip and F.W.G. Leebeek. She studied medicine at the Erasmus MC Rotterdam. Her research focusses on treatment of venous thromboembolism and quality of vitamin K antagonists. During the ISTH congress, she will present the results of the study looking into the impact of PE on long term health outcomes in hospitalized COVID-19 patients.

Presentation(s):

• OC 01.4 - Prevalence of chronic thromboembolic pulmonary hypertension and evaluation of thrombus resolution in COVID-19-associated pulmonary embolism survivors

  Saturday, June 24, 2023
  13:45 – 14:00 ET

• OC 29.2 - The impact of pulmonary embolism on the long-term health outcomes of COVID-19

  Sunday, June 25, 2023
  15:00 – 15:15 ET

• PB0490 - Does a machine learning based algorithm improve dosing of Vitamin K antagonists compared to current decision support programs?

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB1476 - Occurrence of hospital-associated thrombosis despite thromboprophylaxis in the setting of current thromboprophylaxis strategies: an observational cross-sectional study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET